(2026). Apigetrin ameliorates psoriatic inflammation and skin barrier dysfunction via NF-κB/STAT3 pathway in epidermal and dermal cell models. Oriental Pharmacy and Experimental Medicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Apigetrin Ameliorates Psoriatic Inflammation and Skin Barrier Dysfunction via NF-κB/STAT3 Pathway in Epidermal and Dermal Cell Models."
Oriental Pharmacy and Experimental Medicine 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Apigetrin Ameliorates Psoriatic Inflammation and Skin Barrier Dysfunction via NF-κB/STAT3 Pathway in Epidermal and Dermal Cell Models."
Oriental Pharmacy and Experimental Medicine, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.